Nowadays magnetic resonance imaging (MRI) has been profoundly used in radiotherapy (RT) planning to aid the contouring of targets and critical organs in brain and intracranial cases, which is attributable to its excellent soft tissue contrast and multi-planar imaging capability. However, the lack of electron density information in MRI, together with the image distortion issues, precludes its use as the sole image set for RT planning and dose calculation. The purpose of this preliminary study is to probe the feasibility and evaluate an MRI-based radiation dose calculation process by providing MR images the necessary electron density (ED) information from a patient's readily available diagnostic/staging computed tomography (CT) images using an image registration model. To evaluate the dosimetric accuracy of the proposed approach, three brain and three intracranial cases were selected retrospectively for this study. For each patient, the MR images were registered to the CT images, and the ED information was then mapped onto the MR images by in-house developed software generating a modified set of MR images. Another set of MR images with voxel values assigned with the density of water was also generated. The original intensity modulated radiation treatment (IMRT) plan was then applied to the two sets of MR images and the doses were calculated. The dose distributions from the MRI-based calculations were compared to that of the original CT-based calculation. In all cases, the MRI-based calculations with mapped ED yielded dose values very close (within 2%) to that of the CTbased calculations. The MRI-based calculations with voxel values assigned with water density indicated a dosimetric error of 3-5%, depending on the treatment site. The present approach offers a means of utilizing MR images for accurate dose calculation and affords a potential to eliminate the redundant simulation CT by planning a patient's treatment with only simulation MRI and any available diagnostic/staging CT data.
Introduction
The sophistication of modern radiotherapy techniques such as three-dimensional conformal radiation therapy and intensity modulated radiation treatment (IMRT) for brain and intracranial tumors have made the contouring of targets and critical organs a crucial step in the overall RT process because of the exquisite dose conformity and step dose gradients around the targets. Contouring based on planning CT is considered to be the weakest link in the quality chain of the RT process due to inter/intra-observer variability, and subtle visibility of the extent of the tumour (1, 2). In this respect, MRI, which provides excellent soft tissue contrast and multi-planar imaging capability, has been profoundly used to aid contouring in these cases by fusing the MRI with the planning CT (2-7). Studies have shown that the use of MRI in the contouring process greatly improves target volume definition and reduces inter/intra-observer variability (2-4). However, the planning CT seems to be indispensable as it provides the electron density information necessary for the dose calculation with inhomogeneity correction (8, 9).
Studies (10-15) have been done for years to explore the feasibility of MRI-based treatment planning and obviating the redundant planning CT in order to save time and cost of the imaging processes involved. However, the widespread use of MRI-based treatment planning is hampered by three major impediments: (i) the lack of electron density (ED) information in MRI, (ii) the requirement of MRI be performed in treatment position, and (iii) the potential image distortions that lead to geometric inaccuracies. Recently, the advent of open-field MRI scanners, together with sophisticated correction algorithms for image distortion (16, 17) and possible MRI acquisition in the treatment position (7, 18), has shed light on solving the last two problems. Therefore, these confounding issues are anticipated to be solved for MRI-based treatment planning in the near future.
However, present solutions for dose calculation in MRIbased treatment planning still rely solely on an approach that assigns a homogeneous density or bulk-densities to various tissues (assignment methods) in MR images to realize the MRI-based dose calculation. Whilst these methods have been shown to be clinically acceptable in prostate and some brain cases (10-15); there is no guarantee that the assignment methods work equally well in intracranial cases where there are a vast span of tissues with different electron densities such as the air space, sinuses, soft tissues, skull vault, and mastoid bones in the treatment region. Therefore, we propose tackling the problem of the lack of ED information in MR-based treatment planning by providing MR images the necessary ED information from a patient's readily available diagnostic/ staging computed tomography (CT) images using an image registration model. There is no restriction on which CT image set should be used as far as it contains the electron density information of the patient and is performed reasonably close in time to the radiotherapy planning. This modified MRI set possesses the detailed electron density information necessary for accurate dose calculation and yet preserves the excellent image contrast for contouring purposes. Our envisaged ideal paradigm of an MRI-based treatment planning using the proposed modified set of MR images is shown in Figure 1 .
The objective of this work is two-fold: (i) to present a proof of feasibility of mapping electron density information onto MR images from a patient's CT images for dose calculation and (ii) to evaluate the dosimetric accuracy of dose calculation based on the modified MRI with mapped electron density information.
Methods

Preparation of MRI Image Sets
Three brain and three intracranial cases, each with CT (2.5 mm slice) and MRI (1.5T, T1-weighted, 2.5 mm slice, spin echo images) done, were retrospectively selected from our image database. The image matrices of the CT and MR images were both 512 × 512 with a pixel size of 0.49 mm. For each patient, the MR images were registered with the CT images (note that this CT image set only served as a source of ED information), and the ED information from the CT images was mapped onto the MR images on a voxel-by-voxel basis using an in-house developed software to produce a modified set of MRI (mMRI). Another set of registered MR images was generated with voxel values assigned with a homogeneous density of water (aMRI). It follows that the mapped ED distributions on the mMRI and aMRI also have the same resolution of the original CT/MR images for a fair dose comparison with the original plan. A brief description of the metric used in the electron density mapping is given in the following section. The two newly generated MR image sets were then imported into the Eclipse treatment planning system (TPS) (Varian Medical Systems, Palo Alto, CA) as two individual image series.
Electron Density Mapping
Electron density mapping is based on that relative ED or Hounsfield Unit (HU) distribution known in CT images can be propagated onto MR images through a transformation model established by the registration of the two image sets. Given the clinical cases in this study, a rigid registration model was employed to register the CT and MR images and perform the electron density mapping. The metric used was based on mutual information, which has been proven well suited for multimodality image registration (19) (20) (21) (22) and used by our group for contour propagation (23). A rigid transform, including rotational and translational components, was fed into the registration program. The metric function was then optimized with the limited memory Broyden-Fletcher-Goldfarb-Shanno algorithm (24-26) with respect to the transform parameters. The optimizer iteratively varied the parameters and searched for the global minimum of the metric. Upon the successful completion of the registration, the HU (ED information) in each voxel in the CT images was mapped onto the corresponding voxel in the MR images generating the mMRI set.
Structure Contours and Plan Comparison
For each patient, the original treatment plan based on the planning CT set was elected as the 'ground truth' for plan comparison. In order to have a valid comparison, the same set of contours as used in the CT-based plan was copied to the mMRI and aMRI sets. This was accomplished by fusing the mMRI and aMRI sets to the CT set by the built-in image fusion modality in the TPS. Once the copying of the contours was done, the image sets were decoupled and became three individual image sets namely CT, mMRI, and aMRI, each having the same contours.
A simple plan with a single anterior 6 MV open beam measuring 10 cm × 10 cm was applied to the CT, mMRI, and aMRI sets of one of the brain cases. The prescription was 200 cGy to the 100% isodose line. The doses for the three image sets were calculated and the resultant dose distributions were compared. This was to study the dosimetric impact of using mMRI and aMRI in the simplest configuration. In this study, the calculation grid size used in the dose calculation engine was 2 mm, which rendered the image resolution to be less critical on the dose calculation as far as the pixel size was smaller than the grid size.
To study dosimetric impact in a more realistic clinical situation, the original IMRT plan parameters for each patient, including the same isocenter, beam configurations, monitor units, and fluence maps, were applied to the corresponding mMRI and aMRI sets, respectively. The dose calculations were then performed on the mMRI and aMRI sets. The resultant dose distributions, maximum doses, and dose volume histograms (DVHs) of the targets/critical organs of the mMRI-and aMRI-based plans were compared to those of CT-based plan, which served as the 'ground truth'.
Results
Comparison of CT-, mMRI-, and aMRI-based plans
Brain cases: Figure 2 shows the dose distributions on an axial slice of one of the brain cases of the open beam plan from the CT-, mMRI-, and aMRI-based calculations. The dose distributions were similar for all the three calculations except there were two 'dips' of isodose lines (thin arrows) for the CT-and mMRI-based plans. The 'dips' were due to the voids of the skull vault (thick arrows) resulting from the brain surgery. The maximum doses were 120.0%, 119.7%, and 117.8% for the CT-, mMRI-, and aMRI-based plans, respectively.
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Figures 3(A)-3(C) illustrate the dose distributions on the same axial slice of the brain case of the IMRT plan for the three image sets. While the dose distribution from the mMRIbased plan looked quite similar to that of the CT-based plan; the dose distribution from the aMRI-based plan showed a different dose pattern with a receding 80% isodose line and hot spots scattering within the planning target volume (PTV).
The DVH of the PTV for the aMRI-based plan shifted to the high dose end by about 3%. The coverage (V 95 , volume of PTV receiving at least 95% dose) of the PTV for both the mMRI-and aMRI-based plans was slightly compromised when compared to the CT-based plan [Fig 3(D aMRI-based calculation was much larger than those from the other two calculations and there was also a hot area of 105%. The DVH of the PTV from the CT-and mMRI-based plans essentially overlapped whilst that from the aMRI-based plan shifted to the high dose region by about 3% [Fig. 4(D) ].
Intracranial Cases: Figures 5(A)-5(C) show the dose distri-
butions on an axial slice of one of the intracranial cases of the IMRT plan from the CT-, mMRI-, and aMRI-based calculations. The dose distributions from the CT-and mMRI-based plans were almost identical while that from the aMRI-based plan showed a discernible difference. The PTVs in the CTand mMRI-based plans were encompassed by the 98% isodose line, whereas the same PTV in the aMRI-based plan was by 100% isodose line. Figure 5(D) shows the DVHs of the PTV, brainstem, and right parotid gland for the three calculations. There was no significant difference noted for all the DVHs from the CT-and mMRI-based plans. The DVH of the PTV from the aMRI-based plan shifted to the high dose region by about 5%. There was a crossover of the DVH of the right parotid gland for the aMRI-based plan with those of the other two calculations. The maximum dose to the brainstem was about 8% higher for the aMRI-based calculation when compared to the other two calculations. Figure 6 shows the maximum doses of the IMRT plans based on the calculations using CT, mMRI, and aMRI sets, respectively, for all the patients. For every patient, the difference of the maximum dose between the CT-and mMRI-based plans was well within 1%, and the maximum dose from the aMRIbased plan was 2-3% higher than the other two calculations. Figure 7 shows the D 95 (dose to 95% volume of the PTV) of the IMRT plans for the CT-, mMRI-, and aMRI-based plans for the patients studied. For every patient, the difference in D 95 was less than 1% for the CT-and mMRI-based plans, and the D 95 for the aMRI-based plan was 2% higher than the other two calculations.
Maximum doses
PTV Doses
Discussion
For the brain and intracranial cases studied, we have shown that the MRI-based dose calculation using a set of modified MRI with voxel values of electron densities mapped from the corresponding CT image set yielded a comparable result (within 2%) to the CT-based calculation. On the other hand, we found that the dose calculation based on the assignment method produced a dosimetric error of 3-5%, probably because there was a vast span of different electron densities within the treatment region. In fact, this 3-5% error is consistent with the error noted if the inhomogeneity correction is not applied for the CT-based dose calculation for intracranial cases. Ramsey and Oliver (27) have reported the same order of dosimetric error (2-4%) if a homogeneous density of water is used in the intracranial cases for dose calculation. Moreover, in the first presented case, the mMRI method faithfully reflected the impact of the local electron density change on the isodose lines due to the voids in the skull vault (Fig. 1) . It suggested that by merely assigning a homogeneous water density to MR images for dose calculation might not be adequate for a case like this.
One of the limitations of the present study was that the MR images we used were not corrected for spatial distortion because this was a retrospective study; however, it was estimated the typical spatial distortion of a spin echo image within a central view of 20 cm was less than 2 mm (28). Another limitation was on the use of rigid rather deformable image registration for voxel mapping from the CT to the mMRI set. Rigid image registration is inadequate in handling the two image sets where there is organ/target deformation between the two. Yang et al. (29) have shown successful electron density mapping from the planning CT to the cone-beam CT through the use of a deformable image registration for dose calculation. The present approach will definitely benefit from using the deformable image registration for the mapping process.
One might argue that the present approach is also limited by the availability of the most updated CT anatomy of the patient for electron mapping if the MRI simulation is to replace the CT simulation. However, should MRI simulation be implemented, the workflow can somewhat be adjusted to ensure the most updated diagnostic/staging CT is performed reasonably close to the time of MRI simulation.
In this preliminary study, we have shown the feasibility of realizing MRI-based dose calculation; the next step is to address some practical issues in MRI simulation such as image distortions and the provision of digitally reconstructed radiographs (DRRs). Recent studies have shown that MR images used for simulation can be post-processed using distortion correction software which is readily available (10, 12). The recent advent of open-field MRI scanners (16, 17) and sophisticated imaging techniques (7, 18) have enabled MRI be performed in a treatment position and hence provided the basis for generating DRRs necessary for setup verification. Generation of MRI-based DRRs was reported in the literature (27, 30, 31) , but the sub-optimal quality hindered its application in MRI simulation. Our approach might provide a solution for this problem since every voxel in the mMRI set is associated with a HU (electron density information) essential for the projection algorithm to generate a DRR.
Based on the current results from this preliminary study, we envisage that MRI-based dose calculation using mapped electron density is feasible; our further research will focus on a prospective study using deformable image registration for the electron density mapping to improve the MRI-based dose calculation.
Conclusions
In this paper, we present a feasibility of using MRI for dose calculation by electron density mapping. The clinical significance of this lies on that the mMRI not only preserves the excellent image contrast for better delineation of tumors and critical organs but also provides the electron density information necessary for dose calculation. The preliminary study on the clinical cases using the mMRI set yielded a dosimetric discrepancy of less than 2% when compared to the CT-based calculation, which indicates the present approach affords a potential to eliminate the redundant simulation CT by planning a patient's treatment with only MRI simulation and diagnostic/staging CT data. This will, in turn, improve the cost-effectiveness of the overall treatment.
